Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Database
Type of study
Language
Publication year range
1.
Proc Natl Acad Sci U S A ; 109(38): 15407-12, 2012 Sep 18.
Article in English | MEDLINE | ID: mdl-22949678

ABSTRACT

Sensitivity is essential in CD8+ T-cell killing of virus-infected cells and tumor cells. Although the affinity of the T-cell receptor (TCR) for antigen is relatively low, the avidity of T cell-antigen-presenting cell interactions is greatly enhanced by increasing the valence of the interaction. It is known that TCRs cluster into protein islands after engaging their cognate antigen (peptides bound to MHC molecules). Here, we show that mouse K(b) class I molecules segregate into preformed, long-lasting (hours) clusters on the antigen-presenting cell surface based on their bound viral peptide. Peptide-specific K(b) clustering occurs when source antigens are expressed by vaccinia or vesicular stomatitis virus, either as proteasome-liberated precursors or free intracellular peptides. By contrast, K(b)-peptide complexes generated by incubating cells with synthetic peptides are extensively intermingled on the cell surface. Peptide-specific complex sorting is first detected in the Golgi complex, and compromised by removing the K(b) cytoplasmic tail. Peptide-specific clustering is associated with increased T-cell sensitivity: on a per-complex basis, endogenous SIINFEKL activates T cells more efficiently than synthetic SIINFEKL, and wild-type K(b) presents endogenous SIINFEKL more efficiently than tailless K(b). We propose that endogenous processing generates peptide-specific clusters of class I molecules to maximize the sensitivity and speed of T-cell immunosurveillance.


Subject(s)
Antigens, Viral/metabolism , Histocompatibility Antigens Class I/metabolism , Peptides/chemistry , Animals , Antigen Presentation/immunology , Antigen-Presenting Cells/cytology , Antigen-Presenting Cells/metabolism , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/virology , Cell Line , Cytoplasm/metabolism , Golgi Apparatus/metabolism , Mice , Proteasome Endopeptidase Complex/metabolism , beta 2-Microglobulin/metabolism
3.
Blood ; 119(13): 3128-31, 2012 Mar 29.
Article in English | MEDLINE | ID: mdl-22310910

ABSTRACT

Surprisingly little is known about the interaction of human blood mononuclear cells with viruses. Here, we show that monocytes are the predominant cell type infected when peripheral blood mononuclear cells are exposed to viruses ex vivo. Remarkably, infection with vesicular stomatitis virus, vaccinia virus, and a variety of influenza A viruses (including circulating swine-origin virus) induces monocytes to differentiate within 18 hours into CD16(-)CD83(+) mature dendritic cells with enhanced capacity to activate T cells. Differentiation into dendritic cells does not require cell division and occurs despite the synthesis of viral proteins, which demonstrates that monocytes counteract the capacity of these highly lytic viruses to hijack host cell biosynthetic capacity. Indeed, differentiation requires infectious virus and viral protein synthesis. These findings demonstrate that monocytes are uniquely susceptible to viral infection among blood mononuclear cells, with the likely purpose of generating cells with enhanced capacity to activate innate and acquired antiviral immunity.


Subject(s)
Cell Differentiation , Dendritic Cells/physiology , Monocytes/physiology , Virus Diseases/immunology , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/pathology , Cell Differentiation/immunology , Cells, Cultured , Dendritic Cells/immunology , Dendritic Cells/virology , Humans , Influenza A virus/immunology , Influenza A virus/physiology , Influenza, Human/blood , Influenza, Human/immunology , Monocytes/immunology , Monocytes/virology , Time Factors , Vaccinia/blood , Vaccinia/immunology , Vaccinia virus/immunology , Vaccinia virus/physiology , Vesicular Stomatitis/blood , Vesicular Stomatitis/immunology , Vesiculovirus/immunology , Vesiculovirus/physiology , Virus Diseases/physiopathology
4.
J Virol ; 80(12): 6048-55, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16731943

ABSTRACT

The murine cytomegalovirus (MCMV) protein m4/gp34 is unique among known viral genes that target the major histocompatibility complex (MHC) class I pathway of antigen presentation in the following two ways: it is found in association with class I MHC molecules at the cell surface, and it inhibits antigen presentation without reducing cell surface class I levels. The current study was undertaken to define more clearly the structural and cellular requirements for m4/gp34 association with the MHC class I molecule K(b). We first assessed the role of the peptide-loading complex in m4/gp34-K(b) association, using cell lines lacking TAP, tapasin, or beta(2)m. m4/gp34-K(b) complexes formed in the absence of TAP or tapasin, although not as efficiently as in wild-type cells. The expression of full-length and truncation mutants of m4/gp34 in a gutless adenovirus vector revealed that the transmembrane region of m4/gp34 was required for efficient association with the K(b) heavy chain. However, the peptide-loading complex was not absolutely required for the association, since m4/gp34 readily formed complexes with K(b) in detergent lysates. The addition of K(b)-binding peptide to the detergent lysates facilitated but was not essential for the formation of the complexes. The ease of complex formation in detergent lysates contrasted with the small fractions of m4/gp34 and K(b) that form complexes in infected cells, suggesting that the endoplasmic reticulum (ER) environment restricts access of m4/gp34 to K(b). Finally, although m4/gp34-K(b) complexes could form when m4 was carried either by MCMV or by the adenovirus vector, they were only efficiently exported from the ER in MCMV-infected cells, suggesting that MCMV provides additional factors needed for transport of the complexes.


Subject(s)
Carrier Proteins/metabolism , Glycoproteins/metabolism , Histocompatibility Antigens Class I/metabolism , Multiprotein Complexes/metabolism , Muromegalovirus/chemistry , Viral Proteins/metabolism , Animals , Antigen Presentation , Detergents , Endoplasmic Reticulum/metabolism , Membrane Proteins , Mice , Protein Transport
5.
J Virol ; 80(8): 4200-2, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16571839

ABSTRACT

Compared to other organs, murine cytomegalovirus (MCMV) replication in the salivary gland is uniquely resistant to CD8 T-cell control. The contribution of viral genes that interfere with antigen presentation (VIPRs) to this resistance was assessed using a mutant lacking MCMV's known VIPRs. Salivary gland titers of the VIPR-deficient virus were at least 10-fold lower than those of the wild type during the persistent phase of infection; the defect was reversed by depleting CD8 T cells. Thus, VIPRs contribute to CD8 T cells' inability to control virus in the salivary gland.


Subject(s)
Antigen Presentation , CD8-Positive T-Lymphocytes/immunology , Muromegalovirus/physiology , Salivary Glands/virology , Animals , Mice , Mice, Inbred BALB C
6.
Life Sci ; 72(6): 711-9, 2002 Dec 27.
Article in English | MEDLINE | ID: mdl-12467911

ABSTRACT

Three oligosaccharide fractions from the root of Amorphophallus Konjac, which was reported with hypoglycemic effects on diabetes subjects, were isolated and studied using the STZ-treated diabetes model. Among them, one fraction named as KOS-A, was found with nitric oxide (NO(*)) free radical regulation effect, while the other two were not. At concentrations less than 1.5 mM, KOS-A positively decreased STZ-induced NO(*) level of islets, but normal NO(*) release for non-STZ-treated islets was not affected within the range. At 15 mM, KOS-A played a contrary role and increased NO(*) level for islets both with and without STZ-treatment. Islets insulin secretion changed corresponding to NO(*) level in the assay. Increased insulin secretion appeared parallel to the decrease of NO(*), and normal insulin release was not affected by KOS-A less than 1.5 mM. Structure determination of KOS-A shows that it is a tetrasaccharide with Mw of 666 Da and reductive end of alpha-D-mannose. These results indicate that low dosage of KOS-A, with its function on attenuating STZ-induced NO(*) level, doesn't alter normal NO(*) and insulin secretion pathways of isolated islets. The NO(*) attenuation function of KOS-A on the diabetes model is mainly resulted from environmental free radical scavenging by the oligosaccharide. Present results also imply the mechanism of clinical Amorphophallus Konjac hypoglycemic function maybe related with free radical attenuation and lower risks of islets damage from NO(*) radical.


Subject(s)
Amorphophallus , Diabetes Mellitus, Experimental/metabolism , Islets of Langerhans/drug effects , Oligosaccharides/pharmacology , Animals , Diabetes Mellitus, Experimental/drug therapy , Disease Models, Animal , Dose-Response Relationship, Drug , Drug Interactions , Female , Insulin/metabolism , Islets of Langerhans/metabolism , Male , Mice , Nitric Oxide/metabolism , Oligosaccharides/isolation & purification , Oligosaccharides/therapeutic use , Plant Roots/chemistry , Streptozocin
SELECTION OF CITATIONS
SEARCH DETAIL